Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

74 results about "Japanese encephalitis" patented technology

Japanese encephalitis (JE) is an infection of the brain caused by the Japanese encephalitis virus (JEV). While most infections result in little or no symptoms, occasional inflammation of the brain occurs. In these cases, symptoms may include headache, vomiting, fever, confusion and seizures. This occurs about 5 to 15 days after infection.

Method for industrially producing porcine Japanese encephalitis (JE) vaccines by utilizing bioreactor

The invention provides a method for industrially producing porcine Japanese encephalitis (JE) vaccines by utilizing a bioreactor. The method comprises the following steps: (1) sterilizing a microcarrier and the bioreactor, then inoculating cells for vaccine preparation for culturing, inoculating JE viruses when dense monolayers are formed on the cells on the microcarrier, and continuing culturing to reproduce the viruses; (2) stopping culturing and harvesting virus suspension when cytopathy reaches more than 80%; (3) carrying out ultrafilter concentration as well as virus inactivation on the harvested virus suspension; and (4) purifying the inactivated viruses by adopting column chromatography to prepare inactivated vaccines. In the method, the technology of using the microcarrier in the bioreactor for culture is adopted to carry out high density culture of the cells to produce the porcine JE vaccines. Compared with the traditional spinner bottle production method, the method has the following advantages: the automatic control degree is high, so production can be monitored in real time; the labour is saved, thus reducing the cost; the land for production is few, thus being easy to enlarge the scale of production; and the produced viruses have high titer, so the batch-to-batch variation is small, the product quality is stable and the side reaction is low.
Owner:WUHAN CHOPPER BIOLOGY

Method for preparing swine epidemic encephalitis B inactivated vaccine

InactiveCN104208668APrice stabilizationStable immunogenicityViral antigen ingredientsAntiviralsFiberSide effect
The invention provides a method for preparing a swine epidemic encephalitis B inactivated vaccine. According to the method, a Chinese hamster lung cell adaptive virus screened by bacteriophage plaque cloning and purification is capable of generating cytopathic effect, the virulence is stabilized at 107.0-108.0TCID50/mL, and the immunogenicity is stable; the swine epidemic encephalitis B virus is multiplied by utilizing the hamster pulmonary cell system has good virus adaptability and high virus virulence of prepared vaccine. According to the method, a virus concentrating process technology which sequentially performs separating and concentrating is adopted, and virus solution and cell debris can be separated by utilizing a hollow fibrous membrane clarifying and purifying system, so that the problems that the membrane is easily blocked, is sensitive to shearing force and easily aggregated when virus particles are concentrated can be solved, side effects of an inactivated vaccine finished product can be effectively reduced, and the safety of the inactivated vaccine can be improved. Binary ethyleneimine is used as an inactivator instead of formaldehyde and has small destruction on virus antigen, so that the completeness of effective immunogen in the antigen can be guaranteed.
Owner:TIANJIN RINGPU BIO TECH

Preparation method of vaccine for epidemic encephalitis B

The invention relates to a preparation method of a vaccine for epidemic encephalitis B, which comprises the processes of cell culture, virus propagation and vaccine preparation. After cells overgrow with a single layer, a seed culture of viruses and a culture solution are inoculated, and the use quantity of the seed culture of the viruses is that every 100cm<2> of cells is inoculated with 1ml of seed culture of the viruses. The culture solution of the viruses mainly comprises 90-95% of MEM culture solution, 3-5% of calf serum and 7.5% of sodium bicarbonate solution the pH of which is regulated to 7.2-7.6. The vaccine is prepared by adding human serum albumin with the final concentration of 0.3% after being clarified and filtered. The invention adopts an SA14-14-2 attenuated strain to produce an encephalitis purified vaccine. Compared with a vaccine produced by a P3 strain, the attenuated strain is safer and more effective. The invention has the advantages that: (1) the attenuated strain is used for preparing the purified vaccine, which has good safety; (2) the inactivation effect of inactivating the viruses by using beta-propiolactone is good, and an inactivator is naturally degraded and has no residue; and (3) the column chromatography purification property is mild, and the injury to the viruses is small.
Owner:ZHEJIANG TIANYUAN BIO PHARM CO LTD

Traditional Chinese medicine for treating epidemic encephalitis B

A Chinese traditional medicine for curing epidemic type-B encephalitis belongs to a Chinese traditional medicine for curing type-B encephalitis. The ingredients of the medicine are 40g of plaster stone, 10g of rehmannia root, 6g of rhinoceros horn, 5g of coptis, 5g of liquorice, 5g of bamboo leaves, 8g of pittosporm roots and 8g of balloon flower roots; the auxiliary ingredients are 15g of scorpion and 15g of hooked uncaria under the situation of twich and lockjaw; 10g of tabasheer and 10g of articifical bezoar under the situation of much sputum; 12gof moutan bark under the situation of dark purple complexion or maculae on the skin. The medicines used in the prescription are all natural herbs and the Chinese traditional medicine is processed with traditional method; the fetching of material is convenient and the prescription and manufacture method are simple; the expense for manufacturing the medicine is low. The composition of the Chinese herbal medicine is simple and the medicines used in the prescription are all natural ones and the fetching and use are convenient; the manufacture method is simple and the effect is excellent; the price is low; in this way, the herbal medicine is especially fit for people living in remote villages far away from counties and towns; the curing expense for patients with the disease of epidemic type-B encephalitis is low which solves the problem that the household income is low and the life is poor and the medical conditions is deficient locally.
Owner:张贤清
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products